Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice
Drug Metabolism and Disposition · 2024
DOI: 10.1124/dmd.123.001607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Baron J Bechtold und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences (B.J.B., K.D.L., V.O.O., M.R.C., J.D.C.) and Washington Animal Disease Diagnostic Laboratory (L.A.W.), Washingt…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Organic Anion Transporters, Silymarin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCCIH NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences (B.J.B., K.D.L., V.O.O., M.R.C., J.D.C.) and Washington Animal Disease Diagnostic Laboratory (L.A.W.), Washington State University, Pullman, Washington; and Department of Chemistry…
ORCID-Profile: Baron J Bechtold, Victoria O Oyanna, John D Clarke
Förderung
- NCCIH NIH HHS
Zitieren
APA
Bechtold, B. J., Lynch, K. D., Oyanna, V. O., Call, M. R., White, L. A., Graf, T. N., Oberlies, N. H., & Clarke, J. D. (2024). Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001607
Vancouver
Bechtold BJ, Lynch KD, Oyanna VO, Call MR, White LA, Graf TN, et al. Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice. Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.123.001607
BibTeX
@article{Bechtold2024,
author = {Bechtold, Baron J and Lynch, Katherine D and Oyanna, Victoria O and Call, M Ridge and White, Laura A and Graf, Tyler N and Oberlies, Nicholas H and Clarke, John D},
title = {Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice},
journal = {Drug Metabolism and Disposition},
year = {2024},
doi = {10.1124/dmd.123.001607}
}
EUVIMED